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Abstract
Background: Streptococcus pneumoniae is one of the most frequently encountered pathogens in humans but its 
differentiation from closely related but less pathogenic streptococci remains a challenge.
Methods: This report describes a newly-developed PCR assay (Spne-PCR), amplifying a 217 bp product of the 16S 
rRNA gene of S. pneumoniae, and its performance compared to other genotypic and phenotypic tests.
Results: The new PCR assay designed in this study, proved to be specific at 57°C for S. pneumoniae, not amplifying S. 
pseudopneumoniae or any other streptococcal strain or any strains from other upper airway pathogenic species. PCR 
assays (psaA, LytA, ply, spn9802-PCR) were previously described for the specific amplification of S. pneumoniae, but 
psaA-PCR was the only one found not to cross-react with S. pseudopneumoniae.
Conclusion: Spne-PCR, developed for this study, and psaA-PCR were the only two assays which did not mis-identify S. 
pseudopneumoniae as S. pneumoniae. Four other PCR assays and the AccuProbe assay were unable to distinguish 
between these species.
Background
Streptococcus pneumoniae is one of the most pathogenic
bacteria involved in human disease [1], causing bronchi-
tis, pneumonia, as well as life-threatening meningitis and
bloodstream infections [2]. Culture-based methods are
usually applied to detect S. pneumoniae from patient
samples and to differentiate it from other less pathogenic
viridans streptococci, frequently encountered in respira-
tory samples. Differentiation is also important with
regard to resistance testing, since different antibiotic sus-
ceptibility breakpoints are applied for S. pneumoniae with
regard to other viridans species [3]. Culture-based identi-
fication methods usually rely on optochin susceptibility,
agglutination and bile-solubility, sometimes confirmed by
specific probes (Accuprobe™, Genprobe) [4].
However, straightforward phenotypic identification of
pneumococci is hampered by the occurrence of optochin
resistant S. pneumoniae variants [5-8] and. In addition,
closely related S. pseudopneumoniae is difficult to distin-
guish from S. pneumoniae and is e.g. positive with Accu-
Probe as well [4].
It is of clinical relevance to rapidly and specifically
detect S. pneumoniae. Therefore several PCR assays have
been developed over the past decades [9-14].
This study compared the specificity of four published S.
pneumoniae PCR assays to that of a new approach, based
on the 16S rRNA gene. One novelty of this approach
regards the in-silico design of specific primers using pub-
lished Streptococcus sequences, filtered for quality and
annotation-reliability by profile-based methods (Smart-
Gene, Zug, Switzerland). The approach used by this pro-
gram relies on a systematic analysis of all published 16S
rRNA gene sequences for all streptococci (and closely
related organisms), using sequence profiles to eliminate
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Page 2 of 8obviously incomplete or erroneous submissions, which
could induce wrong alignments.
Sequences with a likely incorrect annotation (shown by
low match scores to other sequences of the same species),
with unexpected deletions/insertions, or with non useful
annotations (e.g. "uncultured") were excluded, since they
could induce misleading alignments. Thus, the most rep-
resentative 16S rRNA sequences were determined for
each species. Such a database of representative sequences
was used to align closely related streptococcal species to
identify specific positions in the 16S rRNA gene for the
purpose of species-specific identification. Once these
positions were identified, general searches on relevant
published sequences of S. pneumoniae and closely related
relatives confirmed the consistency of the sequence pat-
tern found. This method helped to detect discriminative
species-specific sequence patterns for S. pneumoniae and
S. pseudopneumoniae, thus saving time and effort




A total of 73 streptococcal strains were analyzed in this
study, as listed in Table 1, i.e. 8 reference strains of Strep-
tococcus mitis [11] and seven reference strains of S. oralis
[11], including three reference strains and the type strain;
19 strains of S. pneumoniae, including two reference
strains and the type strain and including 10 optochin
resistant strains, for which it was concluded in a previous
study [11] that these were genuine S. pneumoniae. In
addition, a total of 30 optochin resistant pneumococcus-
like streptococci already well-characterized in an earlier
study [11], were also included. Finally, the type strain, two
reference strains and one clinical strain of S. pseudopneu-
moniae [4] were included. A total of 12 isolates belonging
to the species Haemophilus influenzae (NCTC 8143T),
Moraxella catarrhalis (ATCC 25238T and clinical isolate
VG S86 0025), Staphylococcus aureus (ATCC 29213 and
NCTC 08530), S. epidermidis (CCM2 124T and CNRS
N860069), Streptococcus agalactiae (LMG 14694T), S.
anginosus (LMG 14502T), S. gallolyticus (LMG 16802T),
S. mutans (LMG 14558T) and S. pyogenes (LMG 14237),
i.e. species also present in the upper airway tract and/or
other Streptococcus species, were used to test the speci-
ficity of primer set Spne1-Spne2Rb. In addition, S. paras-
anguinis (LMG 14537T and LMG 14538) and S. sanguinis
(LMG 14656, LMG 14657 and LMG 14702T) isolates
were used to test the specificity of primer set Spne1-
Spne2Rb.
DNA-extraction was carried out by alkaline lysis as
described previously [15]. always starting from one colony.
spn9802-PCR assay
The amplification reactions were performed as described
previously [9], with minor modifications. Briefly, amplifi-
cation was performed in a reaction mixture of 10 μl, con-
taining 5 μl PCR GoTaqGreen Mix (Promega Benelux,
Leiden, the Netherlands), 2 μM of each of the forward
primer spn9802-143F and the reverse primer spn9802-
304R and 1 μl of the DNA extract. The following thermal
cycling profile was applied, using a Veriti™ Thermal
Cycler (Applied Biosystems, Foster City, Ca.): initial
denaturation at 94°C for 2 min, then 25 cycles consisting
of 94°C for 10 sec, 58°C for 15 sec and 72°C for 1 min, fol-
lowed by a final extension step at 72°C for 5 min. All PCR
products were electrophoresed in 2% agarose gels and
stained with ethidium bromide.
Newly developed PCR assay: 16S rRNA gene based Spne-
PCR assay
Extensive data-mining using commercial software (Inte-
grated Database Network System IDNS™, SmartGene,
Zug, Switzerland), which allows rapid screening of vali-
dated published sequences of species of interest against
other closely related species was used to design primers
for the specific amplification of S. pneumoniae. Primers
were designed to match exactly 2 positions within the 16S
rRNA gene, which allow to distinguish S. pneumoniae
from S. pseudopneumoniae (Figure 1).
Amplifications were performed on an Applied Biosys-
tems Veriti thermal cycler in reaction mixtures of 10 μl
containing 5 μl PCR GoTaqGreen Mix (Promega Bene-
lux, Leiden, the Netherlands), 0.5 μM of each of the two
primers and 1 μl of the DNA extract. The 16S rRNA gene
primers Spne1-Spne2Rb was designed to amplify S. pneu-
moniae, and the stringent annealing temperature was
determined by gradient PCR as 57°C (Figure 2)
The cycling parameters were 94°C for 2 min, followed
by 30 cycles of 10 sec at 94°C, 15 sec at 57°C, 1 min at
72°C, and final extension at 72°C for 5 min. The indicated
primers are amplifying a 217 bp product of the 16S rRNA
gene of S. pneumoniae.
Other PCR assays, i.e. ply- [16], psaA- [17] and lytA-
PCR [18] were described previously [11].
Sequence analysis
Published streptococcal and other 16S rRNA sequences
were extracted from EMBL using proprietary extraction
methods based on sequence profiles and annotation
searches; representative sequences for each species were
determined using a proprietary algorithm developed by
SmartGene for bacterial 16S rRNA sequences (Smart-
Gene IDNS™ Bacteria Module). Sequences were analyzed
and compared using search and alignment functions of
the IDNS™ Bacteria Module of SmartGene. Results were
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Page 3 of 8Table 1: Species and strains studied, phenotypic characteristics, and results for PCR assays
Speciesa Strain Number Original Numberb Spne-PCR psaA-PCR lytA-PCR ply-PCR spn9802-PCR
Streptococcus mitis STR025 LMG 14557T - - - - -
Streptococcus mitis STR056 LMG 14552 - - - - -
Streptococcus mitis STR226 94 03 0728 - - - - -
Streptococcus mitis STR227 94 04 0401 - - - - -
Streptococcus mitis STR228 97 03 2943 - - - - -
Streptococcus mitis STR229 98 05 5898 - - - - -
Streptococcus mitis STR230 98 07 1207 - - - - -
Streptococcus mitis STR231 98 09 0066 - - - - -
Streptococcus oralis STR024 LMG 14553 - - - - -
Streptococcus oralis STR028 LMG 14532T - - - - -
Streptococcus oralis STR029 LMG 14533 - - - - -
Streptococcus oralis STR030 LMG 14534 - - - - -
Streptococcus oralis STR232 94 08 5574 - - - - -
Streptococcus oralis STR233 98 05 5050 - - - - -
Streptococcus oralis STR234 98 10 1512 - - - -
Streptococcus 
parasanguinis
STR031 LMG 14537T - NT NT NT NT
Streptococcus 
parasanguinis
STR032 LMG 14538 - NT NT NT NT
Streptococcus 
sanguinis
STR038 LMG 14656 - NT NT NT -
Streptococcus 
sanguinis
STR039 LMG 14657 - NT NT NT -
Streptococcus 
sanguinis
STR059 LMG 14702T - NT NT NT NT
Streptococcus 
pneumoniae
STR061 LMG 14545Tit> + + + + +
Streptococcus 
pneumoniae
STR062 LMG 15155 + + + + +
Streptococcus 
pneumoniae
STR063 LMG 16738 + + + + +
Streptococcus 
pneumoniae
STR235 93 08 1310 + + + + +
Streptococcus 
pneumoniae
STR236 93 09 03230 + + + + +
Streptococcus 
pneumoniae
STR237 93 09 1111 + + + + +
Streptococcus 
pneumoniae
STR238 98 10 1630 + + + + +
Streptococcus 
pneumoniae
STR239 98 10 3326 + + + + +
Streptococcus 
pneumoniae
STR240 98 10 3367 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR119 KTL004 + + + + +
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pneumoniae. Group I: 
oR C+ A+
STR120 KTL005 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR125 KTL013 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR127 KTL017 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR141 KTL043 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR144 KTL051 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR147 KTL056 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR149 KTL063 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR155a KTL076 + + + + +
Streptococcus 
pneumoniae. Group I: 
oR C+ A+
STR164 KTL093 + + + + +
Streptococcus 
pseudopneumoniae. 
(Group I: oR C+ A+)
STR157 KTL079 - - + + +
Streptococcus 
pseudopneumoniae
STR269 CCUG 48465 - - + + +
Streptococcus 
pseudopneumoniae
STR270 CCUG 49455T - - + + +
Streptococcus 
pseudopneumoniae
STR271 CCUG 50866 - - + + +
Streptococcus sp. 
Group IIa: oR C- A+
STR150 KTL065 - - + + +
Streptococcus sp. 
Group IIa: oR C- A+
STR162 KTL089 - - - + -
Streptococcus sp. 
Group IIa: oR C- A+
STR165 KTL096 - - + + -
Streptococcus sp. 
Group IIb: oR C- A-
STR122 KTL007 - - - + -
Streptococcus sp. 
Group IIb: oR C- A-
STR133 KTL028 - - - + -
Streptococcus sp. 
Group IIb: oR C- A-
STR130 KTL021 - - - + -
Streptococcus sp. 
Group IIb: oR C- A-
STR137 KTL035 - - - + -
Streptococcus sp. 
Group IIb: oR C- A-
STR152 KTL069 - - + + -
Streptococcus sp. 
Group IIb: oR C- A-
STR153 KTL072 - - - + -
Table 1: Species and strains studied, phenotypic characteristics, and results for PCR assays (Continued)
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Group IIb: oR C- A-
STR131 KTL022 - - + - -
Streptococcus sp. 
Group IIb: oR C- A-
STR151 A KTL068 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR118 KTL003 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR121 KTL006 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR136 KTL034 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR138 KTL038 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR145 KTL054 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR154 KTL073 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR123 KTL008 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR128 KTL019 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR132 KTL023 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR134 KTL029 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR139 KTL039 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR158 KTL081 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR159 KTL083 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR156 KTL077 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR140 KTL041 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR160 KTL085 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR161 KTL087 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR135 KTL030 - - - - -
Streptococcus sp. 
Group IIc: oR C- A-
STR143 KTL050 - - - - -
a: oR: optochin resistant, C: capsule, A: AccuProbe.
b: CCUG: Culture Collection of the University of Göteborg, Sweden; KTL: National Public Health Institute, Helsinki, Finland; LMG: LMG, 
Laboratorium voor Microbiologie, Gent Culture Collection.
NT: not tested
Table 1: Species and strains studied, phenotypic characteristics, and results for PCR assays (Continued)
exported as CLUSTAL-A or FASTA files for further anal- collection of 49 optochin resistant alpha-hemolytic strep-
ysis.
Results & Discussion
Previously we reported on encapsulation, AccuProbe
hybridization and psaA, lytA and ply-PCR results for a
tococcal isolates, suspected of being atypical pneumo-
cocci [11]. We concluded that for some strains
identification problems continue to exist, despite the
application of combined genotypic and phenotypic tests
and we found psaA-PCR to be the most specific geno-
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cocci and optochin resistant pneumococci. In addition, in
this study, 16S rRNA gene based primers Spne1 and
Spne2Rb (Spne-PCR) were designed to amplify S. pneu-
moniae isolates and we tested these primers for specific
amplification of S. pneumoniae using the same, previ-
ously well-studied selection of isolates [11], to which
three S. pseudopneumoniae and two S. parasanguinis iso-
lates were added. Also, we tested the specificity of a PCR
assay, i.e. spn9802-PCR [9], that was described in the
meantime for amplification of S. pneumoniae.
All five PCR assays were negative for seven commonly
found respiratory tract species, for 8 S. mitis group iso-
lates, for 7 S. oralis isolates and for the 19 optochin R
streptococcal isolates for which we had already con-
cluded in the previous study [11] that they were non S.
Figure 2 Gradient Spne-PCR results for six S. pneumoniae and two S. pseudopneumoniae isolates. M: marker (100 basepair ladder); lanes 1-6: S. 
pneumoniae isolates STR235 (lane 1), STR236 (lane 2), STR237 (lane 3), STR239 (lane 4), STR144 (lane 5), STR147 (lane 6); lanes 7-8:S. pseudopneumoniae 
isolates STR269 (lane 7) and STR157 (lane 8).
M    1     2      3     4     5    6     7    8    1     2     3     4     5     6     7    8   M    M     1     2      3     4     5    6     7    8   M 
58 °C56 °C 57°C
Figure 1 Sequence and position of the primers, newly developed in this study, specific for amplification of S. pneumoniae, and the homol-
ogous sequences for the S. mitis group species.
Primer Spne1 
 
                                           601                                                      660 
                                            ....:....|....:....|....:....|....:....|....:....|....:....| 
Streptococcus pneumoniae CP000918   | GCGGTTAGATAAGTCTGAAGTTAAAGGCTGTGGCTTAACCATAGTAGGCTTTGGAAACTG 
Streptococcus mitis AY518677   | ..............................................C............. 
Streptococcus oralis GU045378   | ..............................................C............. 
Streptococcus sanguinis CP000387  | ..............................................T............. 
Streptococcus parasanguinis AY281087  | ..............................................C............. 
Streptococcus pseudopneumoniae EU156785 | ............................................................ 
Streptococcus peroris AB008314   | ..............................................C............. 
Streptococcus infantis AY485603  | ..............................................C............. 
Streptococcus cristatus AY188347  | ..............................................C............. 
Streptococcus gordonii AF003931  | ..............................................C............. 
                                         ********************************************** ************* 
Primer Spne2bR 
                                   789                                                      848 
                                   ....:....|....:....|....:....|....:....|....:....|....:....| 
Streptococcus pneumoniae CP000918  | GGGAGCAAACAGGATTAGATACCCTGGTAGTCCACGCTGTAAACGATGAGTGCTAGGTGT 
Streptococcus mitis AY518677    | .....................................C...................... 
Streptococcus oralis GU045378    | .....................................C...................... 
Streptococcus sanguinis CP000387   | .....................................C...................... 
Streptococcus parasanguinis AY281087   | .....................................C...................... 
Streptococcus pseudopneumoniae EU156785 | .....................................C...................... 
Streptococcus peroris AB008314   | .....................................C...................... 
Streptococcus infantis AY485603   | .....................................C...................... 
Streptococcus cristatus AY188347   | .....................................C...................... 
Streptococcus gordonii AF003931   | ......G..............................C...................... 
                                   ****** ****************************** ********************** 
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three S. sanguinis and the two S. parasanguinis isolates.
All five PCR assays were positive for the nine optochin
susceptible S. pneumoniae isolates included and for the
ten optochin resistant streptococci, which had been con-
sidered as S. pneumoniae already, based on the PCR
results from our previous study [11](Table 1).
Thus far, all five PCR assays were found to be equally
specific. However, for a total of 11 optochin R streptococ-
cal isolates, designated during the previous study as
group IIa and group IIb, four were positive with lytA-
PCR, nine with ply-PCR and Spn9802-PCR (9), whereas
none of these isolates yielded a positive result when
tested with psaA-PCR and Spne-PCR.
The S. pseudopneumoniae type strain CCUG 49455T,
the two S. pseudopneumoniae reference isolates CCUG
48465 and CCUG 50866, and one optochin-resistant
pneumococcus-like isolate (KTL079) were positive with
lytA-PCR, ply-PCR and spn9802-PCR, but negative with
Spne-PCR and psaA-PCR. Sequence determination of the
16S rRNA gene (accession number: FJ827123) identified
this clinical isolate unambiguously as S. pseudopneumo-
niae. This isolate was also positive with AccuProbe (Table
1).
Several primer sets have been described for the species
specific amplification of S. pneumoniae. However, in our
hands, the primer sets lytA [18,19], ply [16] and spn9208
[20], were found to amplify strains of S. pseudopneumo-
niae as well. Also the commercial AccuProbe hybridiza-
tion assay yielded a false positive result for the single S.
pseudopneumoniae isolate that was tested by others [4]
and for one strain (KTL079) that was tested by us in our
previous study [11].
The PCR-assay Spne-PCR, described here, is specific
for S. pneumoniae, without cross-reactivity to the four S.
pseudopneumoniae strains tested. The differentiation of
S. pneumoniae from S. pseudopneumoniae is important
since the pathogenic potential of S. pneumoniae is far
higher than that of S. pseudopneumoniae. The clinical rel-
evance of S. pseudopneumoniae has not yet been estab-
lished, although it may be associated with chronic
obstructive pulmonary disease [21].
In addition, the advantage of a specific PCR test on the
basis of the 16S rRNA gene is that there are several copies
of this gene, i.e. 5 to 6 in other Streptococcus species [22]
and 4 copies in the fully sequenced genome of S. pneumo-
niae R6 (AE007317), thus possibly enhancing sensitivity
when this PCR is applied for the direct detection and
identification of S. pneumoniae in clinical samples.
In addition, 16S rRNA gene sequencing is a standard
method in microbial taxonomy and can be applied
directly on the amplified products of this PCR assay to to
help resolve potentially ambiguous results.
Conclusions
Spne-PCR, described here, and psaA-PCR [17] were the
only two out of 5 PCR assays tested, which did not mis-
identify S. pseudopneumoniae as S. pneumoniae. The
approach using representative sequences rather than
unfiltered data from Genbank enabled us to select the
correct sites for reliable species differentiation out of less
relevant and consistent variations and allowed us to
design highly specific primers. Future studies should
enable us to develop an assay specifically for S. pseudo-
pneumoniae and a real-time, multiplex assay for rapid
discrimination of the most important viridans strepto-
cocci in bacterial cultures or patient samples.
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